Novii ECG/EKG System
DeviceExternal fetal heart rate monitoring
NCT Number: NCT03156608
This study will be conducted on women in labor. Fetal heart rate monitoring will be conducting using the Novii Fetal ECG/EMG system and comparing it to current standard of care external fetal heart rate and tocometry. These approaches will be compared with the respect to need for additional monitoring, amount of nursing intervention, cost and satisfaction of patients and healthcare providers.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Intermountain Medical Center, Murray, Utah, United States
Interpretation of fetal heart rate monitoring during labor is one of the most common procedures performed in the practice of obstetrics. Continuous monitoring of the fetal heart rate is used to identify infants at risk for hypoxic ischemic encephalopathy and allow for intervention to prevent this terrible complication. The quality of the fetal heart rate signal is critical for appropriate interpretation of the characteristics that identify risk.
This is a prospective, randomized pragmatic trial comparing the Novii Fetal ECG/EMG system to external fetal heart rate and tocometry (standard of care) for the amount of time of interpretable fetal heart rate during labor. Randomization will occur in blocks based on BMI to control for the potential effect of BMI.
Fetal heart rate tracings from both groups of women will be reviewed in a blinded fashion by experienced Maternal Fetal Medicine (MFM) physicians who will assess the tracing for quality and interpretability. In addition, both approaches will be compared with respect to the need for additional monitoring modalities, amount of nursing intervention, cost and satisfaction of the patients and healthcare providers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
External fetal heart rate monitoring
External fetal heart rate monitoring
Time frame: Time of randomization until time of delivery (up to 48 hours)
Quality of the fetal heart rate for each minute of tracing will be assessed visually by 2 or more blinded reviewers. For the purpose of this study, uninterpretable fetal heart rate will be defined as continuous fetal heart rate data with one or more of the following:
The total number of interpretable minutes of fetal heart tracing and the percentage of time with interpretable fetal heart tracing over the course of labor (Number of minutes with interpretable FHR/Total number of minutes in labor) will be calculated for each patient.
Time frame: Time of randomization until time of delivery (up to 48 hours)
a. Each 10 minute segment will be deemed to be interpretable if it meets all of the following criteria: i. Sufficient data are available to determine a baseline ii. Sufficient data are available to determine the variability of the tracing iii. Sufficient data are available to identify periodic changes in the tracing (e.g. accelerations, decelerations, etc) b. For each 10 minute segment that is called Uninterpretable, the reviewer will indicate the reason for this designation by selecting one of the following options: i. Poor signal quality due to missing data ii. Poor signal quality due to artifact iii. Adequate signal quality but intrinsic fetal heart rate makes interpretation impossible (e.g. marked variability, etc.)
Time frame: Time of randomization until time of delivery (up to 48 hours)
The number of uterine contractions per segment will be recorded b. Signal quality (amount of missing data or artifact) will be recorded
Time frame: Time of randomization until time of delivery (up to 48 hours)
Signal quality (amount of missing data or artifact) will be recorded
Time frame: Time of randomization until time of delivery (up to 48 hours)
Measured by recording the number of times the nurse must adjust the monitoring system to obtain interpretable tracing
Time frame: Time of randomization until time of delivery (up to 48 hours)
Number of times that hand holding of the monitor is required
Time frame: Time of randomization until time of delivery (up to 48 hours)
Need for additional monitoring devices will be determined by the clinical care team including attending physician and/or nurses based on clinical judgment
Time frame: Time of randomization until time of delivery (up to 48 hours)
Reason 1: Poor signal quality - missing data Reason 2: Poor signal - artifact Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference
Time frame: Time of randomization until time of delivery (up to 48 hours)
Reason 2: Poor signal - artifact Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference
Time frame: Time of randomization until time of delivery (up to 48 hours)
Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference
Time frame: Time of randomization until time of delivery (up to 48 hours)
Reason 4: Patient preference Reason 5: Provider preference
Time frame: Time of randomization until time of delivery (up to 48 hours)
Reason 5: Provider preference
Time frame: Time of randomization until time of delivery (up to 48 hours)
We will record the amount of time that the nurses spend at the bedside to adjust the monitor b. Nurses will record the time and reasons that they enter the room
Time frame: Time of randomization until time of delivery (up to 48 hours)
Nurses will record the time and reasons that they enter the room
Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days
Total charge for care from admission to Labor and Delivery to transfer to postpartum care will be recorded for all patients
Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days
Delivery type and indication
Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days
Length of labor recorded
Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days
Type of delivery recorded (e.g., vaginal, cesarean section, etc.)
Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days
Clinical indication for forceps/vacuum extraction or cesarean section delivery
Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days
Amount of blood loss (cc) recorded
Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days
Lacerations and degree of laceration recorded
Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days
Infections documented
Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days
Endometritis diagnosis recorded
Time frame: Hospitalization after delivery - 2-4 days
APGAR scores recorded at 1 minute, 5 minutes, and 10 minutes
Time frame: Hospitalization after delivery - 2-4 days
Recorded NICU admission
Time frame: Hospitalization after delivery - 2-4 days
Infant birthweight (grams)
Time frame: Hospitalization after delivery - 2-4 days
Neonatal sex recorded
Time frame: Up to 7 days after delivery
Satisfaction survey completed by patient after delivery of infant
Time frame: Up to 7 days after delivery
Satisfaction survey completed by nurse attending labor/delivery after delivery of infant
Time frame: Up to 7 days after delivery
Satisfaction survey completed by physician/midwife attending labor/delivery after delivery of infant
Intermountain Health Care, Inc.
Other
Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison
Acronym: Novii
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06787521
Pregnancy Related
Portland, Oregon, United States
View Trial DetailsNCT06640842
Alzheimer Disease, Brain Diseases
Kansas City, Kansas, United States
View Trial DetailsNCT04253626
Anemia, Anemia, Hypochromic
Stanford, California, United States
View Trial DetailsNCT03242174
Lifestyle, Pregnancy Related
Baton Rouge, Louisiana, United States
View Trial Details